Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones.

Escobar C, Byer KJ, Khaskheli H, Khan SR.

J Urol. 2008 Jul;180(1):379-87. doi: 10.1016/j.juro.2008.02.041. Epub 2008 May 21.

2.

Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.

Khan SR.

J Urol. 2013 Mar;189(3):803-11. doi: 10.1016/j.juro.2012.05.078. Epub 2012 Sep 25. Review.

PMID:
23022011
3.

Randall's plaque as the origin of calcium oxalate kidney stones.

Daudon M, Bazin D, Letavernier E.

Urolithiasis. 2015 Jan;43 Suppl 1:5-11. doi: 10.1007/s00240-014-0703-y. Epub 2014 Aug 7. Review.

PMID:
25098906
4.

The role of Randall's plaques in the pathogenesis of calcium stones.

Matlaga BR, Coe FL, Evan AP, Lingeman JE.

J Urol. 2007 Jan;177(1):31-8. Review.

PMID:
17161996
5.

Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.

Khan SR, Thamilselvan S.

Mol Urol. 2000 Winter;4(4):305-12. Review.

PMID:
11156696
6.

Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Evan A, Lingeman J, Coe FL, Worcester E.

Kidney Int. 2006 Apr;69(8):1313-8. Review.

7.

Calcium oxalate stone disease: role of lipid peroxidation and antioxidants.

Selvam R.

Urol Res. 2002 Mar;30(1):35-47. Review.

PMID:
11942324
8.

Physiopathology and etiology of stone formation in the kidney and the urinary tract.

Evan AP.

Pediatr Nephrol. 2010 May;25(5):831-41. doi: 10.1007/s00467-009-1116-y. Epub 2009 Feb 7. Review.

9.

Cell-crystal interactions and kidney stone formation.

Lieske JC, Deganello S, Toback FG.

Nephron. 1999;81 Suppl 1:8-17. Review.

PMID:
9873209
10.

Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something?

Gambaro G, D'Angelo A, Fabris A, Tosetto E, Anglani F, Lupo A.

J Nephrol. 2004 Nov-Dec;17(6):774-7. Review.

PMID:
15593050
11.

The role of calcium phosphate in the development of Randall's plaques.

Tiselius HG.

Urolithiasis. 2013 Oct;41(5):369-77. doi: 10.1007/s00240-013-0602-7. Epub 2013 Aug 21. Review.

PMID:
23963104
12.

Renal tubular damage/dysfunction: key to the formation of kidney stones.

Khan SR.

Urol Res. 2006 Apr;34(2):86-91. Epub 2006 Jan 11. Review.

PMID:
16404622
13.

Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis.

Lieske JC, Toback FG.

Semin Nephrol. 1996 Sep;16(5):458-73. Review.

PMID:
8890401
14.

Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.

Lieske JC, Hammes MS, Toback FG.

Scanning Microsc. 1996;10(2):519-33; discussion 533-4. Review.

PMID:
9813629
15.

Insights on the pathology of kidney stone formation.

Evan AP, Coe FL, Lingeman JE, Worcester E.

Urol Res. 2005 Nov;33(5):383-9. Epub 2005 Aug 3. Review.

PMID:
16078085
16.

Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.

Evan AP, Lingeman JE, Coe FL, Worcester EM.

Semin Nephrol. 2008 Mar;28(2):111-9. doi: 10.1016/j.semnephrol.2008.01.004. Review.

17.

Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles.

Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, Rzewuska E, Miller VM, Lieske JC.

J Investig Med. 2006 Nov;54(7):412-24. doi: 10.2310/6650.2006.06021. Review.

PMID:
17169263
18.

[Calcium kidney stones. Diagnostic and preventive prospects].

Arcidiacono T, Terranegra A, Biasion R, Soldati L, Vezzoli G.

G Ital Nefrol. 2007 Nov-Dec;24(6):535-46. Review. Italian.

PMID:
18278757
19.
20.

Metabolic syndrome: a multifaceted risk factor for kidney stones.

Domingos F, Serra A.

Scand J Urol. 2014 Oct;48(5):414-9. doi: 10.3109/21681805.2014.903513. Epub 2014 Apr 8. Review.

PMID:
24708398

Supplemental Content

Support Center